MedTrace Logo

Radiomics and Molecular Expression Predictive Model for Esophago-Gastric Junction and Gastric Cancer TRG

NCT04878783 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 138

Last updated 2024-05-09

No results posted yet for this study

Summary

The aim of this study is to develop a CT scan-based radiomics predictive model about tumor regression grade (TRG) in patients with esophago-gastric junction (EGJ) ang gastric cancer undergoing perioperative chemotherapy. The molecular expression of the neoplasms will be evaluated to assess its association with the TRG and the radiomic features.

Conditions

Interventions

DIAGNOSTIC_TEST

CT scan

Patients undergoing CT scan staging for gastric and EJ junction cancer + perioperative chemotherapy (FLOT regimen) , CT scan re-staging and radical gastrectomy or esophagogastrectomy will be enrolled in the study

Sponsors & Collaborators

  • Andrea Laghi

    collaborator UNKNOWN

  • University of Roma La Sapienza

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-20
Primary Completion
2024-10-01
Completion
2027-10-30

Countries

  • Italy
  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04878783 on ClinicalTrials.gov